Investigation on financial toxicity among cancer patients receiving chemotherapy

Investigation on financial toxicity among cancer patients receiving chemotherapy - Financial toxicity in cancer patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000025043

Enrollment

150

Registered

2016-11-30

Start date

2016-11-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant tumor

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cancer patients receiving chemotherapy for at least 2 months(including neoadjuvant or adjuvant chemotherapy) in Aichi Cancer Center

Exclusion criteria

Exclusion criteria: Patients deemed unable to complete questionnaire due to physical or mental conditions

Design outcomes

Primary

Measure	Time frame
Reliability and validity of Japanese translation of Comprehensive score for financial toxicity(COST) for the evaluation of financial toxicity among Japanese cancer patients receiving chemotherapy	—

Secondary

Measure	Time frame
Factors that influence financial toxicity Association between financial toxicity and survival	—

Countries

Japan

Contacts

Public ContactKazunori Honda

Aichi Cancer Center Hospital Department of Clinical Oncology

khonda@aichi-cc.jp+81-52-762-6111

Outcome results